Amporin Pharmaceuticals Companies
Amporin Pharmaceuticals seeks to create a new class of small-molecule medications that block and eradicate harmful soluble oligomers and holes found within cell membranes.
Connections
Industry:
Neuro Medicine (Tech and Pharma)
Founded Date:
2024
Headquarters:
Basel, Basel-Stadt, Switzerland
Estimated Revenue:
$369.19 million